Building a Purpose Driven Digital Oncology Platform to Deliver World Class Cancer Care by R. Venkataramanan, Founder CEO, @karkinoshealthcare


KARKINOS HEALTHCARE (KH) is desirous to build an end-to-end technology driven oncology focused managed healthcare platform where almost no person is deprived of care either by lack of access or by affordability.

The design and delivery will be through bespoke solutions for cancer care, as a one stop shop in experience, addressing core market needs for this specialized health care. It will use technology and AI based continuous feedback to improvise care to our own needs, the learnings of which will be scaled up within India and beyond. Karkinos Healthcare is supported by an eclectic Founding Team with strong technology, healthcare and finance experience, and a panel of eminent Clinical Advisors in India and abroad. The team’s efforts are further augmented by its access to best-inclass architects, space planners, vendors, technology support engineers, pharma partners – all of whom combine to create the firm’s USP in the field of cancer care delivery. The team of Karkinos Healthcare has, in their earlier avatars, facilitated the design, development and commissioning of a 700-bed Specialty Oncology Hospital and the redesign/ modernization of an existing hospital, aggregating to 1 million square feet in less than a year’s time. Both have since been commissioned and are fully operational. In addition, they have also been instrumental in the design and development of a ‘hub & spoke’ Cancer Care hospital network in the North East of India that comprises of 12 hospitals, presently under construction. The Distributed Cancer Care Network model (DCCN) also finds a mention in Lancet Oncology.


With gross underreporting and inadequate diagnosis, there is a high burden of Cancer in India with almost 1.9 million new cases per year. More than ~50% cancer patients visit a doctor for the first time, at or past the third stage of cancer, thereby requiring multi-modal therapy, spread over 2-3 years and finally succumb to the disease. Cancer puts a massive personal and financial burden on not only the patient, but also on the patient’s entire family with the out-of-pocket expenses being as high as 70% of the total treatment cost. Along with the loss of working days for the patient there is loss for the family and resultant detriment to GDP. With the rise in cancer cases across the country, and lack of adequate cancer care infrastructure and medical professionals, there is a need to assess the cancer care requirement better and prepare to bridge the demand- supply gap by improving accessibility, availability and affordability of cancer care. In addition, there is also an urgent need for extensive early detection and prevention initiatives given the remarkably high tobacco consumption and low awareness in the country. The cancer care diagnostic and delivery platform in India is presently woefully inadequate. Multiple players mostly operate in silos thereby contributing to a health care infrastructure that is fragmented, inaccessible by patients and thus leading to the unsatisfactory patient experience. Existing data in the public domain and market research has demonstrated a significant gap in the supply of oncology beds, linear accelerators, radiotherapy technicians and oncologists. With ever-increasing demand from patients seeking treatment, the demand/supply gap widens with the passage of time. This is the unaddressed opportunity. However, there is a need to revisit the operating model and encourage the establishment of participatory systems rather than proprietary systems.


Karkinos Healthcare aims to significantly enhance access to cancer care services by creating a technology enabled data driven platform wherein the knowledge architecture is centralized, and the delivery systems are democratized and distributed. The solution encompasses a ‘hub- and-spoke and further spoke’ hospital infrastructure on the back of robust technology and clinical decision support systems that enables service delivery in a wide patient catchment. The model relies on a technology backbone that enables anchor referral hospital/s that cater to complex cases, surgery, and radiotherapy supported by a network of smaller centers for catering to diagnosis and ongoing treatment so that the treatment can be decentralized, thereby reducing the load on Apex centers for non- complex treatment while increasing accessibility and cutting down on loss of productive days for the family. The network is designed to be ‘wired’ to enable connectivity amongst all centers, seamless access to data, diagnostics, and patient consulting – which includes a combination of a central knowledge repository, diagnostic capabilities, and a common training HR pool. It is, therefore, essential that the ‘hub and spoke and further spoke’ cancer care hospital network be supported by core investments in infrastructure (“Karkinos cloud” and a clinical workflow orchestration and care coordination engine). This would entail tools/apps that will help collect data from Tier 3-4 medical clinics and aggregation & reporting from Tier 1-2 hospitals. The architecture will focus on the creation of the Karkinos backbone infrastructure and open APIs followed by a few “core apps”. Some of the apps would be open source for the developer community to emulate and develop more apps required by the Karkinos network. The priority of these applications is driven by customers, the diagnostics and treatment modalities that they currently have, and their maturity in handling clinical data.

The data collected will be key drivers of understanding specific genomic profiles of tumours with the clinical annotation that will aid

a) A technology platform for diagnosis and data mining

b) A shared services infrastructure training facility and ongoing clinical R & D

Karkinos Healthcare strongly believes that technology will be the key enabler for the de- centralization of expert care. The technology platform consists of a distributed architecture with the development of tools/applications that will integrate seamlessly and securely to a Karkinos backbone in drug discovery, diagnostics and treatment strategies This will nurture innovation and newer therapeutic approaches to improve outcomes, in addition, to becoming a strong revenue generator. The clinical data repository, curated knowledge base and advance analytics will be part of the Karkinos offerings.


Detection & Diagnosis – Establishment of participatory systems and near home care, Research on genomics as a foundation approach for prevention, Innovation and game-based outreach approach for early diagnosis and wellness.

Data & Research – Contribute towards Atmanirbhar Bharat through drug discovery research and treatment innovation, Large scale screening and longitudinal data to build robust AI/ML analytics, predictive models and clinical decision support system for real world evidence.

Deliver managed health care – 2 million+ patients served annually, 10 million+ patient hours saved annually.


Karkinos Healthcare over the next 18 months, will be focused on creating the foundation for the following components –

• a state-of-the-art technology platform curated for oncology.

• a knowledge network with medical protocols, surgical skills, digital pathology center.

• along with fifty Level 4, fifteen Level 3, five Level 2 and one Level 1 centres.

The article was first published on the K-Vani Blog by Karkinos Healthcare, it has been republished here with the author’s permission, link to the article

R. Venkataramanan
R. Venkataramanan

Venkat is Founder and CEO of Karkinos Healthcare. He is currently engaged as an Advisor to the Chairman, Reliance Industries Limited, India’s largest private sector company.

Prior to his association with Reliance, Venkat spent more than a decade and a half with the Tata Group in various capacities. His last assignment in the Tata Group was as Managing Trustee of the Tata Trusts wherein he was responsible for the operations, oversight and co-ordination between the various Tata Trusts.

In his role as the Chief Executive Officer of the Tata Trusts, Venkat was engaged in redefining the Tata Trusts’ strategic approach with a view to making it relevant and responsive to the current needs of society while remaining within the mandate established by the Settlors. He was directly overseeing several large initiatives within the Trusts viz “Lakhpati Kisan – an program that aims to significantly enhance rural prosperity in under privileged and deprived communities, redefining Cancer Care across the country, technology enabled education initiatives in partnership with Massachusetts Institute of Technology (MIT) and the sanitation and nutrition projects in collaboration with Govt., of India.

He has over two decades of business and operations experience in the areas of finance, business support and strategy. From early 2007 to end 2012, he was Executive Assistant to Mr. Ratan N. Tata, the former Chairman of the Tata Group. During his stint in the Chairman’s office of Tata Sons, Venkat was part of several significant projects including the Tata Motors acquisition of Jaguar Land Rover, launch of the small car Nano, creation of several Joint Ventures, responses in operating companies during the 2008 financial crisis etc., and was also privy to several senior leadership transitions and change management processes in the Tata Group. On behalf of the Chairman, he was the key point person to several entities in India and abroad.

Prior to his stint with Mr. Tata’s office, Venkat was associated as Head of Business Support at the Qatar Foundation, a not for profit entity engaged in Education, Science and Community development based in Doha, wherein he played a key role in establishing partnerships with a number of leading US universities.

Venkat is a Science graduate and has done his MBA from the Sri Satya Sai University, Puttaparthi. He is also a Law Graduate from Mumbai University and has completed his Advanced Management Program (AMP) from the Harvard Business School. He is currently pursuing his EngD from the University of Warrick, UK on role of Technology in Health Care Systems.

Over the past several years, in his personal capacity, Venkat actively supported Mr. Ratan Tata in his investments in the technology, digital and e-commerce space that have now begun to attract significant attention in India and abroad. He was also the CEO of UC-RNT Fund, a US$ 350 million VC fund that Mr. Tata established in collaboration with the University of California. A key proponent of societal platforms, he is the midst of incubating alternative business and investment vehicles that work in the intersection of business, philanthropy, non-profits and governments on the notion of sustainable shared value creation for societal benefit

– Advisor to Chairman, Reliance Industries Ltd
– Chief of Staff to Chairman, Tata Sons and Managing Trustee of Tata Trusts
– Tata Memorial Hospital and Tata Medical Centre Trust, conceived Tata Centers for cancer care
– CEO and Partner of UC-RNT Fund and RNT Capital Advisors, a $350 million fund

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top
👋 Hello
Hello!! 👋 Manish here, Thanks for visiting The Healthcare IT Experts Blog !! How can i help you?